Clinical Trial Update: Evaluating Refractive and Visual Outcomes With the Alcon Toric ReSTOR +2.5 and +3.0 Models [NA]

View source ↗

Summary

Completed clinical trial evaluating refractive and visual outcomes with Alcon Toric ReSTOR +2.5 and +3.0 models.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Alcon Toric ReSTOR +2.5 (Bausch? (unspecified))
• Alcon Toric ReSTOR +3.0 (Bausch? (unspecified))

Snippet

Sponsor: Gainesville Eye Associates | Conditions: Cataract | NA | Status: COMPLETED | Results posted: 2021-08-06